Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.

Breast cancer research and treatment - 1 Feb 2010

Figueiredo Jane C, Haile Robert W, Bernstein Leslie, Malone Kathleen E, Largent Joan, Langholz Bryan, Lynch Charles F, Bertelsen Lisbeth, Capanu Marinela, Concannon Patrick, Borg Ake, Børresen-Dale Anne-Lise, Diep Anh, Teraoka Sharon, Torngren Therese, Xue Shanyan, Bernstein Jonine L

Abstract excerpt

The potential effects of oral contraceptive (OC) and postmenopausal hormone (PMH) use are not well understood among BRCA1 or BRCA2 (BRCA1/2) deleterious mutation carriers with a history of breast cancer. We investigated the association between OC and PMH use and risk of contralateral breast cancer (CBC) in the WECARE (Women's Environment, Cancer, and Radiation Epidemiology) Study. The WECARE Study is a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Chromatography, High Pressure Liquid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Contraceptives, Oral

Share to Estrogen Replacement Therapy

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Heterozygote

Share to Neoplasms, Second Primary

Source

Open in PubMed Open full text

Identifiers

PMID: 19597986
DOI: 10.1007/s10549-009-0455-5
PMCID: PMC2835545

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.PMID 19597986Read ↗

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.Semantic proximity Read ↗

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.Semantic proximity Read ↗

Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.Semantic proximity Read ↗

Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.Semantic proximity Read ↗

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.Semantic proximity Read ↗

Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.Semantic proximity Read ↗

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.Semantic proximity Read ↗

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.Semantic proximity Read ↗

Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.